Sphera Funds Management Ltd.
- SEC CIK
- 0001496201
- Latest filing
- Aug 14, 2026
Holdings in Q4 2025
Holdings as of Dec 31, 2025, filed Feb 17, 2026. Long positions only; changes compare share counts with Q3 2025.
- Positions
- 94
- −7 vs. Q3 2025
- Portfolio value
- $478.5M
- +$56.9M (+13.5%) vs. Q3 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 1,123,525 | $35.1M | 7.3% | −383,500−25.4% | Reduced | History |
| BIIBBiogen Inc. | COM | 94,738 | $16.7M | 3.5% | +12,000+14.5% | Added | History |
| MLYSMineralys Therapeutics, Inc. | COM | 449,003 | $16.3M | 3.4% | +229,093+104.2% | Added | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 762,563 | $16.0M | 3.3% | +374,847+96.7% | Added | History |
| NVMINova Ltd. | COM | 47,846 | $15.7M | 3.3% | +3,950+9.0% | Added | History |
| TSEMTower Semiconductor Ltd | SHS NEW | 122,513 | $14.4M | 3.0% | −189,289−60.7% | Reduced | History |
| COGTCogent Biosciences, Inc. | COM | 378,500 | $13.4M | 2.8% | +279,974+284.2% | Added | History |
| AZNAstraZeneca PLC | SPONSORED ADR | 135,060 | $12.4M | 2.6% | 00.0% | Unchanged | History |
| SNYSanofi | SPONSORED ADR | 239,515 | $11.6M | 2.4% | +20,000+9.1% | Added | History |
| LLYEli Lilly & Co | Stock | 9,040 | $9.72M | 2.0% | −1,000−10.0% | Reduced | History |
| FOLDAmicus Therapeutics, Inc. | COM | 658,377 | $9.38M | 2.0% | −332,765−33.6% | Reduced | History |
| IMTXImmatics N.V. | SHS | 861,105 | $9.04M | 1.9% | +278,000+47.7% | Added | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 147,000 | $8.74M | 1.8% | +147,000 | New | History |
| BBIOBridgeBio Pharma, Inc. | COM | 107,746 | $8.24M | 1.7% | +67,000+164.4% | Added | History |
| ORICOric Pharmaceuticals, Inc. | COM | 1,004,378 | $8.22M | 1.7% | +572,685+132.7% | Added | History |
| DYNDyne Therapeutics, Inc. | COM | 392,894 | $7.69M | 1.6% | −33,624−7.9% | Reduced | History |
| TRVITrevi Therapeutics, Inc. | COM | 598,534 | $7.49M | 1.6% | −45,423−7.1% | Reduced | History |
| JNJJohnson & Johnson | Stock | 35,831 | $7.42M | 1.5% | −5,000−12.2% | Reduced | History |
| SVRASavara Inc | COM | 1,178,164 | $7.10M | 1.5% | −172,169−12.8% | Reduced | History |
| SRRKScholar Rock Holding Corp | COM | 158,265 | $6.97M | 1.5% | +158,265 | New | History |
| WVEWave Life Sciences, Inc. | SHS | 408,166 | $6.94M | 1.5% | +358,166+716.3% | Added | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 300,623 | $6.91M | 1.4% | −51,935−14.7% | Reduced | History |
| HELPHelus Pharma Inc. | COM NEW | 825,576 | $6.75M | 1.4% | +455,200+122.9% | Added | History |
| ANNXAnnexon, Inc. | COM | 1,316,212 | $6.61M | 1.4% | −478,175−26.6% | Reduced | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 837,889 | $6.54M | 1.4% | +837,889 | New | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 239,764 | $6.51M | 1.4% | +32,000+15.4% | Added | History |
| SLNOSoleno Therapeutics Inc | COM | 136,314 | $6.31M | 1.3% | +94,708+227.6% | Added | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 250,961 | $6.30M | 1.3% | +187,301+294.2% | Added | History |
| GSKGSK plc | ADR | 122,000 | $5.98M | 1.3% | 00.0% | Unchanged | History |
| ENPHEnphase Energy, Inc. | Stock | 186,500 | $5.98M | 1.2% | +159,800+598.5% | Added | History |
| NVONovo Nordisk A S | ADR | 115,677 | $5.89M | 1.2% | +10,000+9.5% | Added | History |
| CYTKCytokinetics Inc | COM NEW | 91,717 | $5.83M | 1.2% | −69,800−43.2% | Reduced | History |
| ABBVAbbVie Inc. | Stock | 25,256 | $5.77M | 1.2% | 00.0% | Unchanged | History |
| SEDGSolaredge Technologies, Inc. | COM | 196,536 | $5.67M | 1.2% | +55,570+39.4% | Added | History |
| ACADAcadia Pharmaceuticals Inc | COM | 212,202 | $5.67M | 1.2% | +63,302+42.5% | Added | History |
| VORVor Biopharma Inc. | COM NEW | 410,417 | $5.37M | 1.1% | +410,417 | New | History |
| MRKMerck & Co., Inc. | Stock | 48,600 | $5.12M | 1.1% | 00.0% | Unchanged | History |
| NVSNovartis AG | ADR | 37,000 | $5.10M | 1.1% | 00.0% | Unchanged | History |
| FBRXForte Biosciences, Inc. | COM NEW | 185,869 | $5.07M | 1.1% | −288,440−60.8% | Reduced | History |
| KODKodiak Sciences Inc. | COM | 175,500 | $4.91M | 1.0% | +175,500 | New | History |
| TNGXTango Therapeutics, Inc. | COM | 544,563 | $4.82M | 1.0% | +544,563 | New | History |
| Solaredge Technologies, Inc.83417MAE4 | NOTE 2.250% 7/0 | 4,000,000 | $4.70M | 1.0% | 00.0% | Unchanged | – |
| ATXSAstria Therapeutics, Inc. | COM | 355,725 | $4.66M | 1.0% | +104,500+41.6% | Added | History |
| MDWDMediWound Ltd. | SHS NEW | 230,347 | $4.25M | 0.9% | +45,077+24.3% | Added | History |
| CAMTCamtek Ltd | ORD | 39,498 | $4.20M | 0.9% | +10,450+36.0% | Added | History |
| RVMDRevolution Medicines, Inc. | COM | 52,500 | $4.18M | 0.9% | −7,500−12.5% | Reduced | History |
| AMDAdvanced Micro Devices Inc | Stock | 18,040 | $3.86M | 0.8% | +2,570+16.6% | Added | History |
| CLYMClimb Bio, Inc. | COM | 932,247 | $3.73M | 0.8% | +497,410+114.4% | Added | History |
| ACOGAlpha Cognition Inc. | COM NEW | 567,616 | $3.69M | 0.8% | +228,864+67.6% | Added | History |
| ELVNEnliven Therapeutics, Inc. | COM | 226,765 | $3.49M | 0.7% | +60,000+36.0% | Added | History |
| TARAProtara Therapeutics, Inc. | COM STK | 650,000 | $3.46M | 0.7% | +650,000 | New | History |
| AVGOBroadcom Inc. | Stock | 9,755 | $3.38M | 0.7% | +3,200+48.8% | Added | History |
| ELDNEledon Pharmaceuticals, Inc. | COM | 2,132,131 | $3.22M | 0.7% | +851,898+66.5% | Added | History |
| BIOABioAge Labs, Inc. | COM | 243,035 | $3.22M | 0.7% | +243,035 | New | History |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 407,709 | $3.14M | 0.7% | 00.0% | Unchanged | History |
| ESLTElbit Systems Ltd | Stock | 5,340 | $3.08M | 0.6% | −1,400−20.8% | Reduced | History |
| KURAKura Oncology, Inc. | COM | 295,522 | $3.07M | 0.6% | +50,000+20.4% | Added | History |
| MAZEMaze Therapeutics, Inc. | COM | 71,843 | $2.98M | 0.6% | −82,500−53.5% | Reduced | History |
| ZIMZIM Integrated Shipping Services Ltd. | SHS | 136,005 | $2.89M | 0.6% | +136,005 | New | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 41,000 | $2.85M | 0.6% | −132,931−76.4% | Reduced | History |
| EVMNEvommune, Inc. | COM SHS | 166,147 | $2.84M | 0.6% | +166,147 | New | History |
| VSTMVerastem, Inc. | COM NEW | 343,678 | $2.65M | 0.6% | +265,371+338.9% | Added | History |
| AMGNAmgen Inc | Stock | 7,500 | $2.45M | 0.5% | −2,000−21.1% | Reduced | History |
| NRIXNurix Therapeutics, Inc. | COM | 124,000 | $2.35M | 0.5% | +124,000 | New | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 11,000 | $2.35M | 0.5% | +11,000 | New | History |
| TENXTenax Therapeutics, Inc. | COM NEW | 190,111 | $2.32M | 0.5% | +190,111 | New | History |
| JANXJanux Therapeutics, Inc. | COM | 157,840 | $2.18M | 0.5% | +72,000+83.9% | Added | History |
| PFEPfizer Inc | Stock | 86,000 | $2.14M | 0.4% | 00.0% | Unchanged | History |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 368,146 | $2.02M | 0.4% | −40,000−9.8% | Reduced | History |
| CTNMContineum Therapeutics, Inc. | CL A | 173,475 | $1.98M | 0.4% | +173,475 | New | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 3,300 | $1.92M | 0.4% | +3,300 | New | History |
| PHVSPharvaris N.V. | COM | 63,953 | $1.77M | 0.4% | −55,453−46.4% | Reduced | History |
| VRNSVaronis Systems Inc | COM | 52,500 | $1.72M | 0.4% | −21,400−29.0% | Reduced | History |
| DTILPrecision Biosciences Inc | COM NEW | 396,116 | $1.65M | 0.3% | +396,116 | New | History |
| VTYXVentyx Biosciences, Inc. | COM | 180,114 | $1.63M | 0.3% | −260,000−59.1% | Reduced | History |
| IBITiShares Bitcoin Trust ETF | ETF | 30,055 | $1.49M | 0.3% | +8,600+40.1% | Added | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 145,371 | $1.35M | 0.3% | −30,000−17.1% | Reduced | History |
| VYGRVoyager Therapeutics, Inc. | COM | 339,761 | $1.34M | 0.3% | +140,000+70.1% | Added | History |
| TRDAEntrada Therapeutics, Inc. | COM | 110,942 | $1.14M | 0.2% | +110,942 | New | History |
| TNYATenaya Therapeutics, Inc. | COM | 1,500,000 | $1.07M | 0.2% | +1,500,000 | New | History |
| CATXPerspective Therapeutics, Inc. | COM NEW | 349,973 | $962.4K | 0.2% | −160,370−31.4% | Reduced | History |
| BMYBristol Myers Squibb Co | Stock | 17,500 | $944.0K | 0.2% | 00.0% | Unchanged | History |
| JSPRJasper Therapeutics, Inc. | COM NEW | 485,401 | $888.3K | 0.2% | −144,069−22.9% | Reduced | History |
| PEPGPepGen Inc. | COM | 121,467 | $790.8K | 0.2% | −50,000−29.2% | Reduced | History |
| STTKShattuck Labs, Inc. | COM | 195,212 | $712.5K | 0.1% | +195,212 | New | History |
| PALIPalisade Bio, Inc. | COM | 184,100 | $432.6K | 0.1% | +184,100 | New | History |
| HOWLWerewolf Therapeutics, Inc. | COM | 626,810 | $397.1K | 0.1% | 00.0% | Unchanged | History |
| SKYESkye Bioscience, Inc. | COM NEW | 478,928 | $359.1K | 0.1% | 00.0% | Unchanged | History |
| PRLDPrelude Therapeutics Inc | COM | 122,752 | $356.0K | 0.1% | +122,752 | New | History |
| APREAprea Therapeutics, Inc. | COM NEW | 270,000 | $230.3K | <0.1% | 00.0% | Unchanged | History |
| OKUROnKure Therapeutics, Inc. | COM CL A | 60,454 | $175.3K | <0.1% | 00.0% | Unchanged | History |
| MREOMereo BioPharma Group plc | SPON ADS | 255,400 | $106.4K | <0.1% | +255,400 | New | History |
| PMNProMIS Neurosciences Inc. | COM SHS | 11,807 | $80.6K | <0.1% | 00.0% | UnchangedConverted for a 1-for-25 split | History |
| APLTApplied Therapeutics, Inc. | COM | 50,000 | $5.00K | <0.1% | 00.0% | Unchanged | History |
Options (5)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| PRAXPraxis Precision Medicines, Inc. | COM NEW | – | $11.8M |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $8.54M | – |
| RAREUltragenyx Pharmaceutical Inc. | COM | – | $8.05M |
| NICENICE Ltd. | SPONSORED ADR | – | $6.30M |
| iShares Tr464287432 | 20 YR TR BD ETF | – | $4.10M |
Sold out since Q3 2025 (29)
Positions held at the end of Q3 2025 that are gone from this filing.
| Security | Class | Shares in Q3 2025 | Value in Q3 2025 | % of portfolio in Q3 2025 | History |
|---|---|---|---|---|---|
| NICENICE Ltd. | SPONSORED ADR | 157,400 | $22.8M | 5.4% | History |
| Invesco QQQ Trust Series I46090E103 | ETF | 22,960 | $13.8M | 3.3% | – |
| CDTXCidara Therapeutics, Inc. | COM NEW | 75,743 | $7.25M | 1.7% | History |
| CLBTCellebrite DI Ltd. | ORDINARY SHARES | 298,948 | $5.54M | 1.3% | History |
| RAPPRapport Therapeutics, Inc. | COM | 157,533 | $4.68M | 1.1% | History |
| IMVTImmunovant, Inc. | COM | 256,743 | $4.14M | 1.0% | History |
| ENGNenGene Therapeutics Inc. | COM | 504,409 | $3.45M | 0.8% | History |
| RZLTRezolute, Inc. | COM NEW | 363,947 | $3.42M | 0.8% | History |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 57,901 | $3.07M | 0.7% | History |
| AMZNAmazon Com Inc | Stock | 13,760 | $3.02M | 0.7% | History |
| METAMeta Platforms, Inc. | Stock | 3,924 | $2.88M | 0.7% | History |
| ORAOrmat Technologies, Inc. | COM | 29,000 | $2.79M | 0.7% | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 100,000 | $2.72M | 0.6% | History |
| CEVACeva Inc | COM | 81,085 | $2.14M | 0.5% | History |
| TECXTectonic Therapeutic, Inc. | COM | 115,908 | $1.82M | 0.4% | History |
| PCVXVaxcyte, Inc. | COM | 50,000 | $1.80M | 0.4% | History |
| IMNMImmunome Inc. | COM | 147,200 | $1.72M | 0.4% | History |
| MISTMilestone Pharmaceuticals Inc. | COM | 820,000 | $1.64M | 0.4% | History |
| QUREuniQure N.V. | SHS | 24,900 | $1.45M | 0.3% | History |
| BHVNBiohaven Ltd. | COM | 91,155 | $1.37M | 0.3% | History |
| BCAXBicara Therapeutics Inc. | COM | 85,747 | $1.35M | 0.3% | History |
| SABSSAB Biotherapeutics, Inc. | COM NEW | 566,395 | $1.14M | 0.3% | History |
| LRMRLarimar Therapeutics, Inc. | COM | 260,385 | $841.0K | 0.2% | History |
| ROIVRoivant Sciences Ltd. | SHS | 42,571 | $644.1K | 0.2% | History |
| ETNB89bio, Inc. | COM | 39,675 | $583.2K | 0.1% | History |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 71,010 | $509.1K | 0.1% | History |
| CMMBChemomab Therapeutics Ltd. | SPONSORED ADS | 179,425 | $471.9K | 0.1% | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 12,496 | $431.0K | 0.1% | History |
| DSGNDesign Therapeutics, Inc. | COM | 21,918 | $165.0K | <0.1% | History |